L'ancien directeur créatif d'Assassin's Creed Hexe a partagé son expérience avec l'intelligence artificielle d'OpenAI il y a peu. Pour lui, cette tentative d'apprentissage de la programmation informat ...

Une simple page Web peut-elle en apprendre davantage sur votre activité que vous ne l’imaginez ? Des chercheurs viennent de démontrer qu’un mécanisme méconnu des navigateurs modernes peut être détourn ...

Veronica Beagle is the managing editor for Education at Forbes Advisor. She completed her master’s in English at the University of Hawai‘i at Mānoa. Before coming to Forbes Advisor she worked on ...

A recent Stack Overflow survey found that more than 84% of developers are already using or planning to use AI tools in their workflow. After trying OpenAI Codex for myself, I understand why. Like many ...

What's CODE SWITCH? It's the fearless conversations about race that you've been waiting for. Hosted by journalists of color, our podcast tackles the subject of race with empathy and humor. We explore ...

May 30, 2026 • The Supreme Court is about to rule on whether states can ban transfeminine student athletes from playing on girls' and women's teams. But we're talking to journalist Imara Jones about ...

Transforming drug development, Myomaker Bio's lab-grown muscle platforms offer human-relevant models for effective preclinical testing and risk reduction. Evosep announces the launch of Evosep ...

Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Eric's career includes extensive work in both public and corporate accounting with ...

An immunology research group at an Ivy League university is using the VIAFLO 96 and VIAFLO 384 handheld electronic pipettes from INTEGRA Biosciences to streamline its ELISA workflows. Clocking up 90 ...

The Medical News Today news team reports on emerging science, cutting-edge research, new treatments, and trending topics in health and medicine. All articles are written by our network of editors and ...

A recent paper in Nature Biotechnology examines problems and solutions for antibody-based therapies for solid pancreatic cancers and tumors of the head and neck.